Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Radium-223 Plus Enzalutamide Ups Survival in Prostate Cancer
BARCELONA, Spain — Adding bone-targeting radium-223 (Ra223) to the androgen receptor pathway inhibitor enzalutamide (Xtandi) in patients with metastatic castration-resistant prostate cancer and bone metastases significantly improves survival outcomes, according to the first results from the PEACE III trial. The…
English